Publications by authors named "VARGA K"

The effect of prophylaxis with oral or intramuscular vitamin K1 (Konakion) on the hypoprothrombinaemia and on the rate of detectable acarboxyprothrombin of full-term newborns was investigated. Factor II clotting activity, factor II activity by Echis carinatus venom, factor II protein concentration and acarboxyprothrombin were determined in four groups of breast-fed infants. In the untreated group and in the group where the babies received vitamin K1 orally at birth the factor, II clotting activity was decreased and the rate of acarboxyprothrombin positive cases was increased significantly (from 30% and 28% to 55% and 52% respectively) at the 3d and 5-7th days of age.

View Article and Find Full Text PDF

A non-invasive, fully automatic blood pressure monitoring system was developed to make the diagnosis of hypertension more accurate and to help individualizing antihypertensive therapy. The system consists of two subunits: the automatic microprocessor-controlled blood pressure monitor (Nippon Colin Co. BP 203) and a microcomputer system (Commodore 64).

View Article and Find Full Text PDF

Haemodynamic and humoral effects of captopril were studied in patients with essential and renovascular hypertension. Captopril decreased significantly both systolic and diastolic blood pressure and moderately, it reduced also the heart rate. On the basis of the haemodynamic effects our patients could be divided into two groups: in patients where the total peripheral resistance (TPR) exceeded 2000 dyn x sec x cm-5 during rest, captopril exerted its hypotensive effect by decreasing TPR.

View Article and Find Full Text PDF

The irreversible effects of pressure (1-2000 atm) upon the enzymatic activity and structure of the Ca2+-ATPase of sarcoplasmic reticulum were investigated. Sarcoplasmic reticulum vesicles suspended in a medium of 0.1 M KCl, 10 mM imidazole, pH 7.

View Article and Find Full Text PDF

Analysis of the effect of naloxone (0.4 mg iv.) on clonidine hypotension in 80 patients with essential hypertension revealed that two groups could be separated.

View Article and Find Full Text PDF

Daily doses of 0.3 mg clonidine and 3 mg guanfacine were equiactive in decreasing blood pressure and heart rate in 17 subjects with essential hypertension. Clonidine decreased cardiac output and guanfacine decreased total peripheral resistance, while clonidine had no effect on stroke volume but guanfacine increased it.

View Article and Find Full Text PDF

The effects of clonidine, naloxone, and their combination on arterial blood pressure (BP), heart rate (HR), and hemodynamic and biochemical parameters were examined in 29 patients with essential hypertension. Treatment for 3 days with 0.3 mg/day clonidine reduced BP and HR, and these effects were quickly reversed by a single injection of 0.

View Article and Find Full Text PDF

Diurnal rhythm of plasma beta endorphin was established with the highest level in the morning and the lowest one at midnight in normotensive subjects and also in patients with essential hypertension. Clonidine (300 micrograms daily) significantly increased plasma beta endorphin concentrations only in the hypertensive patients. The significant linear correlation between the increase in plasma beta endorphin concentration and the decrease in blood pressure (both systolic and diastolic) in these patients may point to the role of this endogenous opioid in the antihypertensive action of clonidine.

View Article and Find Full Text PDF

A group of rats was fed on control liquid diet, while another group was fed on liquid diet containing alcohol up to 36% of the total calories. After 4, 8 and 12 weeks of treatment ECG, haematocrit, histological structure of the heart, blood pressure, cardiac output, distribution of the organ fraction of cardiac output (by Sapirstein's method and 85Sr labelled microsphere technique), nutritive blood flow and circulatory resistance of the organs were studied. A mild repolarization disturbance was shown by the ECG record of the alcohol exposed animals.

View Article and Find Full Text PDF

Changes of G-6-PDH activity was studied in the human placental tissue during various stages of gestation. Enzyme activity diminished progressively at the end of pregnancy. Our observation indicated that the G-6-PDH activity of placental tissue is highest in the term pregnancy as activity in other tissues.

View Article and Find Full Text PDF